
LevTech Lifesciences develops polymeric heart valves made from proprietary biostable polymers designed for long-term durability without the need for anticoagulants. Their FORMOSUS valves feature novel designs optimized through AI-guided computational modeling and machine learning to maximize hydrodynamic performance and minimize mechanical fatigue. The company employs an automated, cost-effective manufacturing process. The valves are investigational, not FDA approved, and clinical safety and efficacy have not yet been demonstrated. LevTech targets the heart valve replacement market with innovative polymer technology and AI-driven design optimization.

LevTech Lifesciences develops polymeric heart valves made from proprietary biostable polymers designed for long-term durability without the need for anticoagulants. Their FORMOSUS valves feature novel designs optimized through AI-guided computational modeling and machine learning to maximize hydrodynamic performance and minimize mechanical fatigue. The company employs an automated, cost-effective manufacturing process. The valves are investigational, not FDA approved, and clinical safety and efficacy have not yet been demonstrated. LevTech targets the heart valve replacement market with innovative polymer technology and AI-driven design optimization.